Status:
COMPLETED
Mind Body Intervention for COVID-19 Long Haul Syndrome
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
COVID-19 Long Haul Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The present study is a feasibility study in which we will determine if a mind-body program that we have previously developed for chronic back pain can improve the multiple somatic complaints associate...
Detailed Description
This study is a pilot and feasibility study to determine if a mind-body program that we have previously developed for chronic back pain can improve the multiple somatic complaints associated with the ...
Eligibility Criteria
Inclusion
- Adult patient ≥ 18 years old
- New symptoms attributed to the post-covid long-haul syndrome (extremity pain, dyspnea, headaches, chest pain, fatigue) occurring after an acute phase of COVID19
- Minimum of at least 12 weeks after the end of the acute phase of COVID-19 infection
- Persistence of symptoms for a least 1 month with no identified other organic etiology
- Score ≥ 3 or more on the SSS-8 score
- Symptoms present for a minimum of 4 days a week
- Willingness to consider mind-body intervention
Exclusion
- Patients \< 18 years of age
- Patients \> 60 years of age
- Diagnosed (non-COVID-19) organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome (note that pain related to disc disease is not an exclusion unless there are neurological impairments).
- Patients with previous severe COVID-19 disease, defined as those who had been admitted to the ICU or have objective evidence of ongoing organ injury (e.g., persistent chest radiographic abnormalities or myocarditis)
- Identified lung or cardiac injury in subjects with chest pain or dyspnea (e.g., chest radiograph abnormalities, cardiac ultrasound showing myocarditis or depressed ejection fraction )
- Patients with a diagnosis of significant psychiatric comorbidities such as schizophrenia or dementia
Key Trial Info
Start Date :
May 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 9 2022
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT04854772
Start Date
May 15 2021
End Date
August 9 2022
Last Update
August 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215